PortfoliosLab logoPortfoliosLab logo
ISIN
US92337C1045
CUSIP
92337C104
IPO Date
Jan 27, 2012

Highlights

Market Cap
$421.38M
Enterprise Value
$332.25M
EPS (TTM)
-$2.35
Total Revenue (TTM)
$49.59M
Gross Profit (TTM)
$25.91M
EBITDA (TTM)
-$209.89M
Year Range
$3.55 - $11.25
Target Price
$18.50
ROA (TTM)
-85.14%
ROE (TTM)
-237.18%

Share Price Chart


Loading charts...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Verastem, Inc.

Performance

VSTM Performance Chart

Verastem, Inc. (VSTM) is down 45.0% since the beginning of the year. At $4 per share, VSTM is trading 62.2% below its 52-week high of $11. Investors who bought $1,000 worth of VSTM shares 5 years ago would now be looking at an investment worth $83.


Loading charts...

S&P 500 Index

Returns By Period

Verastem, Inc. (VSTM) has returned -44.95% so far this year and -13.79% over the past 12 months. Over the last ten years, VSTM has returned -12.26% per year, falling short of the S&P 500 Index benchmark, which averaged 13.88% annually.


Verastem, Inc.

1D
3.16%
1M
0.24%
YTD
-44.95%
6M
-46.20%
1Y
-13.79%
3Y*
-21.45%
5Y*
-39.19%
10Y*
-12.26%

Benchmark (S&P 500 Index)

1D
-0.37%
1M
-0.01%
YTD
9.16%
6M
8.64%
1Y
25.22%
3Y*
19.78%
5Y*
11.99%
10Y*
13.88%
*Multi-year figures are annualized to reflect compound growth (CAGR)

VSTM Monthly Returns History

Based on dividend-adjusted daily data since Jan 27, 2012, VSTM's average daily return is +0.07%, while the average monthly return is +1.09%. At this rate, an investment would double in approximately 5.3 years.

Historically, 43% of months were positive and 57% were negative. The best month was May 2023 with a return of +161.1%, while the worst month was Sep 2015 at -70.6%. The longest winning streak lasted 5 consecutive months, and the longest losing streak was 8 months.

On a daily basis, VSTM closed higher 45% of trading days. The best single day was May 26, 2023 with a return of +125.6%, while the worst single day was Sep 28, 2015 at -67.4%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-20.98%-6.23%-7.34%3.02%-20.70%-1.85%-44.95%
202517.60%-7.98%7.77%24.21%0.40%-44.81%48.67%49.92%-4.54%7.02%12.59%-27.44%49.32%
202444.35%6.04%-5.30%-15.42%-60.32%-24.75%-12.75%-3.85%19.60%25.75%42.02%-3.18%-36.49%
202360.72%-19.66%-20.11%-5.92%161.14%-39.22%48.66%-11.75%-16.70%-22.76%9.71%18.14%68.53%
2022-25.37%-21.57%17.50%0.71%-9.86%-9.37%-7.76%8.41%-26.72%-50.59%9.52%-12.50%-80.37%
2021-8.45%20.51%5.11%24.29%26.06%5.17%-20.64%-17.96%16.23%-15.58%2.69%-23.22%-3.76%

Benchmark Metrics

Verastem, Inc. has an annualized alpha of -2.88%, beta of 1.46, and R2 of 0.07 versus S&P 500 Index. Calculated based on daily prices since January 27, 2012.

  • This stock participated in 185.05% of S&P 500 Index downside but only 30.18% of its upside - more exposed to losses than it benefited from rallies.
  • R2 of 0.07 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
-2.88%
Beta
1.46
0.07
Upside Capture
30.18%
Downside Capture
185.05%

Return for Risk

Risk / Return Rank

VSTM ranks 36 for risk / return — below 36% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


VSTM Risk / Return Rank: 3636
Overall Rank
VSTM Sharpe Ratio Rank: 3535
Sharpe Ratio Rank
VSTM Sortino Ratio Rank: 3838
Sortino Ratio Rank
VSTM Omega Ratio Rank: 3737
Omega Ratio Rank
VSTM Calmar Ratio Rank: 3636
Calmar Ratio Rank
VSTM Martin Ratio Rank: 3535
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Verastem, Inc. (VSTM) and compare them to S&P 500 Index.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


VSTMBenchmarkDifference
Sharpe ratioReturn per unit of total volatility

-2.21

Sortino ratioReturn per unit of downside risk

-2.47

Omega ratioGain probability vs. loss probability

1.03

1.37

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.21

2.78

-2.99

Martin ratioReturn relative to average drawdown

-0.39

12.44

-12.83

Dividends

Dividend History


Verastem, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading charts...

Worst Drawdowns

The table below displays the maximum drawdowns of the Verastem, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Verastem, Inc. was 98.96%, occurring on Aug 5, 2024. The portfolio has not yet recovered.

The current Verastem, Inc. drawdown is 97.98%.


Related event

Drawdown

Fall

Recovery

Underwater

2024 bear market2024
-98.96%Aug 2024
11y 28d
12y 11moJul 2013 - now
2012 bear market2012
-46.13%Nov 2012
8mo 15d6mo 25d
1y 3moMar 2012 - Jun 2013
2012 pullback2012
-7.52%Mar 2012
3d7d
10dMar 2012 - Mar 2012
2012 pullback2012
-6.22%Feb 2012
7d4d
11dFeb 2012 - Feb 2012
2012 pullback2012
-4.56%Feb 2012
9d7d
16dJan 2012 - Feb 2012

Drawdown Indicators


VSTMBenchmarkDifference

Max Drawdown

Largest peak-to-trough decline

-98.96%

-56.78%

-42.18%

Max Drawdown (1Y)

Largest decline over 1 year

-66.39%

-9.10%

-57.29%

Max Drawdown (3Y)

Largest decline over 3 years

-84.36%

-18.90%

-65.46%

Max Drawdown (5Y)

Largest decline over 5 years

-95.86%

-25.43%

-70.43%

Max Drawdown (10Y)

Largest decline over 10 years

-98.16%

-33.92%

-64.24%

Current Drawdown

Current decline from peak

-97.98%

-1.80%

-96.18%

Average Drawdown

Average peak-to-trough decline

-75.32%

-10.71%

-64.61%

Ulcer Index

Depth and duration of drawdowns from previous peaks

35.07%

2.03%

+33.04%

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading charts...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Verastem, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Verastem, Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for VSTM relative to other companies in the Biotechnology industry. Currently, VSTM has a P/S ratio of 7.1. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items
Portfolio Analyzer

Build a portfolio with VSTM

Add Verastem, Inc. to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Analyzer with VSTM